[The treatment of bronchial inflammatory diseases with a new drug association with mucolytic and expectorant activity].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000150:complications; D003371:Cough / Q000188:drug therapy; D004653:Empyema / Q000150:complications; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006139:Guaiacol / Q000627:therapeutic use*; D006801:Humans; D007251:Influenza, Human / Q000150:complications; D008171:Lung Diseases / Q000150:complications; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D005100:Expectorants; D000644:Quaternary Ammonium Compounds; D006139:Guaiacol
Il trattamento delle forme inflammatorie bronchiali con una nuova associazione ad attivitá mucolitica ed espettorante.